Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.7K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.1K
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Intramuscular Fat Infiltration With Incident Venous Thromboembolism: A Population-Based Cohort Study.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Author Correction: Targeted apoptosis of macrophages and osteoclasts in arthritic joints is effective against advanced inflammatory arthritis.

Nature communications·2026
Same author

Eu<sup>3+</sup>-mediated ratiometric fluorescence visualization sensing for traceability and content prediction of plant-derived products: an example of Chrysanthemi Flos.

Talanta·2026
Same author

The gut-joint axis in osteoarthritis.

Nature reviews. Rheumatology·2026
Same author

Glucagon-like peptide-1: a critical link between gut microbiota dysbiosis and degenerative musculoskeletal diseases.

Gut microbes·2026
Same author

The application of large language models in orthopedic postgraduate education: potentials, challenges, and future prospects.

Journal of orthopaedic surgery and research·2026

Related Experiment Video

Updated: Apr 16, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

12.2K

RUNX2 and Osteosarcoma.

Na Li, Dongwei Luo, Xiaoxia Hu

  • 1Department of Hematology and Hematological Laboratory Science, Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, China. luyaojuan19@gmail.com.

Anti-Cancer Agents in Medicinal Chemistry
|March 5, 2015
PubMed
Summary

RUNX2, a key factor in bone formation, plays a complex role in osteosarcoma (OS) development and metastasis. Understanding its function is crucial for designing new OS treatment strategies.

More Related Videos

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study
02:35

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

1.7K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.5K

Related Experiment Videos

Last Updated: Apr 16, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

12.2K
Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study
02:35

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

1.7K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.5K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma (OS) is the most common pediatric bone cancer.
  • Osteoblast activity and abnormal bone formation are hallmarks of OS.
  • RUNX2 is a critical transcription factor for osteoblast differentiation.

Purpose of the Study:

  • To review the role of RUNX2 in osteosarcoma (OS) etiology and pathogenesis.
  • To summarize the oncogenic properties of RUNX2 in human OS.
  • To explore RUNX2's involvement in OS metastasis and bone metastasis in other cancers.

Main Methods:

  • Literature review of osteosarcoma pathogenesis.
  • Summary of studies on RUNX2's oncogenic properties in OS.
  • Discussion of RUNX2's role in OS metastasis and bone metastasis.

Main Results:

  • RUNX2 may regulate cell cycle control in pre-osteoblasts, contributing to OS development.
  • RUNX2 is implicated in OS metastasis and bone metastasis in prostate and breast cancers.
  • RUNX2's interaction with microRNAs in OS pathogenesis is highlighted.

Conclusions:

  • RUNX2 has a multifaceted role in OS pathogenesis, influencing tumorigenesis and metastasis.
  • Further research into RUNX2's mechanisms can inform OS treatment strategies.
  • This review provides a comprehensive understanding of RUNX2's function in OS.